Edesa Biotech, Inc. (EDSA) intrinsic value & 10-year financials
Edesa Biotech, Inc. (EDSA) has a Graham intrinsic value of $34.33 per share. At $2.57 on Oct 17, 2026, the stock trades 93% below that value.
- Graham intrinsic value
- $34.33
- Share price (Oct 17, 2026)
- $2.57
- Price vs Graham value
- 93% below
- Market cap
- $22.7M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- -28.7%
- ROIC (10-yr avg)
- 160.5%
- Free cash flow (FY2025)
- —
EDSA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$7.2M | — | — | — | -806.4% |
| FY2024 | — | -$6.2M | — | — | — | -529.5% |
| FY2023 | — | -$8.4M | — | -$6.6M | — | -464.7% |
| FY2022 | — | -$17.5M | — | -$12.3M | — | -487.3% |
| FY2021 | $0 | -$13.3M | — | -$13.7M | — | -996.8% |
| FY2020 | $328.8K | -$6.4M | — | -$5.0M | -1946.7% | 4876.6% |
| FY2019 | — | — | — | — | — | — |
| FY2018 | $0 | -$5.0M | — | -$5.0M | — | -54.4% |
| FY2017 | $50.0K | -$5.0M | — | -$5.0M | -10449.1% | -53.0% |
| FY2016 | $1.3M | -$5.0M | -$0.57 | -$4.9M | -386.0% | -39.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Edesa Biotech, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Edesa Biotech, Inc. has historically struggled to out-earn its cost of capital, averaging just -14.6% ROIC.
Edesa Biotech, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Edesa Biotech, Inc. is modeled at -28.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $34.33 per share.